Evolus Pre-Tax Profit Margin 2016-2024 | EOLS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Evolus pre-tax profit margin from 2016 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Evolus pre-tax profit margin from 2016 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$198.6B
Stryker (SYK)	$139.1B
Boston Scientific (BSX)	$123.3B
Medtronic (MDT)	$114.7B
EssilorLuxottica (ESLOY)	$106.1B
Haleon (HLN)	$47.7B
Lonza Group Ag (LZAGY)	$46.2B
ResMed (RMD)	$35.7B
Koninklijke Philips (PHG)	$29.1B
Terumo (TRUMY)	$28.6B
Zimmer Biomet Holdings (ZBH)	$21.7B
Baxter (BAX)	$19.8B
Insulet (PODD)	$16.7B
Smith & Nephew SNATS (SNN)	$13.5B
Bio-Rad Laboratories (BIO)	$9.6B
Demant (WILYY)	$9.2B
BellRing Brands (BRBR)	$7.7B
Lantheus Holdings (LNTH)	$7.5B
ICU Medical (ICUI)	$4.4B
TG Therapeutics (TGTX)	$3.9B
Haemonetics (HAE)	$3.8B
Neogen (NEOG)	$3.8B
Perrigo (PRGO)	$3.8B
GN Store Nord (GNNDY)	$3.7B
Prestige Consumer Healthcare (PBH)	$3.7B
Envista Holdings (NVST)	$3.3B
QuidelOrtho (QDEL)	$3.1B
Agios Pharmaceuticals (AGIO)	$2.7B
Maravai LifeSciences Holdings (MRVI)	$2.2B
Green Thumb Industries (GTBIF)	$2.2B